ANGPT2 is a nearly endothelial cell-specific cytokine that promotes vascular remodeling in an autocrine pathway, and its circulating level has been reported to be in association with the progression of metastasis in melanoma patients, particularly in stage III/IV melanoma patients [40,41,42]. This evidence concerns the gene ANGPT2 and melanoma.